The role of corticotropin-releasing factor in the pathophysiology of depression

Implications for antidepressant mechanisms of action

Elizabeth I. Martin, Charles Nemeroff

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

An overwhelming and ever-growing literature support the hypothesis that the CRF-ergic neurons, including extrahypothalamic as well as HPA axis components, represent a seminal stress-response system, which plays a causal role in the etiology of affective and anxiety disorders. Data have also demonstrated a role for CRF-ergic circuitry in the mechanism of action of current antidepressant therapies. The temporal sequence of symptom improvement during treatment with these agents more closely matches normalization of CRF-ergic signaling and HPA axis functioning than their primary effects on monoaminergic systems. Moreover, CRF1 antagonists are known to possess antidepressant and anxiolytic properties and likely represent a novel class of antidepressants/anxiolytics that may be used both in monotherapy as well as in combination with currently available treatments.

Original languageEnglish
Pages (from-to)260-266
Number of pages7
JournalPsychiatric Annals
Volume38
Issue number4
DOIs
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Antidepressive Agents
Anti-Anxiety Agents
Depression
Anxiety Disorders
Mood Disorders
Neurons
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The role of corticotropin-releasing factor in the pathophysiology of depression : Implications for antidepressant mechanisms of action. / Martin, Elizabeth I.; Nemeroff, Charles.

In: Psychiatric Annals, Vol. 38, No. 4, 01.04.2008, p. 260-266.

Research output: Contribution to journalArticle

@article{f305deb0bab94fd8b90e6b0e7f9db37b,
title = "The role of corticotropin-releasing factor in the pathophysiology of depression: Implications for antidepressant mechanisms of action",
abstract = "An overwhelming and ever-growing literature support the hypothesis that the CRF-ergic neurons, including extrahypothalamic as well as HPA axis components, represent a seminal stress-response system, which plays a causal role in the etiology of affective and anxiety disorders. Data have also demonstrated a role for CRF-ergic circuitry in the mechanism of action of current antidepressant therapies. The temporal sequence of symptom improvement during treatment with these agents more closely matches normalization of CRF-ergic signaling and HPA axis functioning than their primary effects on monoaminergic systems. Moreover, CRF1 antagonists are known to possess antidepressant and anxiolytic properties and likely represent a novel class of antidepressants/anxiolytics that may be used both in monotherapy as well as in combination with currently available treatments.",
author = "Martin, {Elizabeth I.} and Charles Nemeroff",
year = "2008",
month = "4",
day = "1",
doi = "10.3928/00485713-20080401-02",
language = "English",
volume = "38",
pages = "260--266",
journal = "Psychiatric Annals",
issn = "0048-5713",
publisher = "Slack Incorporated",
number = "4",

}

TY - JOUR

T1 - The role of corticotropin-releasing factor in the pathophysiology of depression

T2 - Implications for antidepressant mechanisms of action

AU - Martin, Elizabeth I.

AU - Nemeroff, Charles

PY - 2008/4/1

Y1 - 2008/4/1

N2 - An overwhelming and ever-growing literature support the hypothesis that the CRF-ergic neurons, including extrahypothalamic as well as HPA axis components, represent a seminal stress-response system, which plays a causal role in the etiology of affective and anxiety disorders. Data have also demonstrated a role for CRF-ergic circuitry in the mechanism of action of current antidepressant therapies. The temporal sequence of symptom improvement during treatment with these agents more closely matches normalization of CRF-ergic signaling and HPA axis functioning than their primary effects on monoaminergic systems. Moreover, CRF1 antagonists are known to possess antidepressant and anxiolytic properties and likely represent a novel class of antidepressants/anxiolytics that may be used both in monotherapy as well as in combination with currently available treatments.

AB - An overwhelming and ever-growing literature support the hypothesis that the CRF-ergic neurons, including extrahypothalamic as well as HPA axis components, represent a seminal stress-response system, which plays a causal role in the etiology of affective and anxiety disorders. Data have also demonstrated a role for CRF-ergic circuitry in the mechanism of action of current antidepressant therapies. The temporal sequence of symptom improvement during treatment with these agents more closely matches normalization of CRF-ergic signaling and HPA axis functioning than their primary effects on monoaminergic systems. Moreover, CRF1 antagonists are known to possess antidepressant and anxiolytic properties and likely represent a novel class of antidepressants/anxiolytics that may be used both in monotherapy as well as in combination with currently available treatments.

UR - http://www.scopus.com/inward/record.url?scp=44349173715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349173715&partnerID=8YFLogxK

U2 - 10.3928/00485713-20080401-02

DO - 10.3928/00485713-20080401-02

M3 - Article

VL - 38

SP - 260

EP - 266

JO - Psychiatric Annals

JF - Psychiatric Annals

SN - 0048-5713

IS - 4

ER -